REIG JOFRE UK LIMITEDActive

Company number 09301085Private limited companyIncorporated 2014

Key figures

£5,207,985+0.3%
Net assets 2024
-0.0%
Average annual change 2021–2024
02 m4 m6 m2021202220232024

Like most small UK companies, REIG JOFRE UK LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 m10 m2021202220232024
Filed accounts2021–2024
2021202220232024
Turnover2,422,9663,558,609——
Profit for the year1,74960,668——
Cash at bank and in hand135,082292,268309,59997,937
Total assets4,257,6674,948,2395,692,0008,084,820
Total liabilities330,541524,977497,4652,876,835
Net assets / total equity5,214,2315,274,8995,194,5355,207,985
Average number of employees0012

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2024

pharmaceutical distribution

As described in the company's latest filed accounts.

Summary: REIG JOFRE UK LIMITED

Company

REIG JOFRE UK LIMITED is a private limited company registered with Companies House under company number 09301085. It was incorporated on 7 Nov 2014. Its status is active. The registered office is in Totnes (TQ9). Its nature of business (SIC 2007) is manufacture of pharmaceutical preparations (21200).

Accounts

The latest accounts in the database are for 2024 (period ending 31 Dec 2024); the company files small company accounts. Net assets were £5,207,985, up 0.3% on the previous year. Cash at bank and in hand was £97,937. Total assets were £8,084,820 and total liabilities £2,876,835. The company had an average of 2 employees. Figures are available for 4 financial years (2021–2024).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 21 Nov 2026.